In glioma patients, SIRT5 is significantly downregulated compared with healthy controls, with a highly significant p -value of less than 0.0001 [ 94 ].
← all excerpts
Sirtuins in Central Nervous System Tumors-Molecular Mechanisms and Therapeutic Targeting.
1
—
—